Nagashima, Kana <br/><br/>
Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission.  [electronic resource] 

 -  Clinical case reports  Mar 2020 
 - 466-468 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2050-0904 
<br/><br/><label>Standard No.: </label>10.1002/ccr3.2688  doi